Skip to content

Effect of Gait Relearning Robot for Individuals After Stroke

Randomized Controlled Trial on the Effectiveness and Safety of Gait Relearning Robot for Individuals After Stroke - RCTESGRRIAS

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs052200011
Enrollment
72
Registered
2020-05-12
Start date
2020-09-02
Completion date
Unknown
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait disorder after stroke Post-stroke, Gait disorders, lower limb

Interventions

"Robot Assist Gait Training (RAGT) group" Conventional training
conduct stretching, muscle strengthening, balance training as necessary on 40min/day for 1week. Robot Assist Gait Training
walking with Robot on 20min/day for 1week. "Control group" Conventional training
conduct stretching, muscle strengthening, balance training as necessary on 40min/day for 1week. Conventional gait training
walking without Robot on 20min/day for 1week.
rehabilitation

Sponsors

Maki Takakuni
Lead Sponsor
Ohata Koji
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Individuals with hemiplegia after first stroke. 2.Individuals within 6 months after the onset of stroke. 3.Individuals who can walk independently using walking aids (canes, walkers, AFO, etc.). 4.Individuals who have walking ability that were classified Functional Ambulation Category II or more, and motor function estimated as Brunnstrom Recovery Stage II-VI.

Exclusion criteria

Exclusion criteria: 1.Individuals who have high cognitive decline and higher brain dysfunction, and it is difficult to understand with the research explanation. 2.Individuals with movement restriction due to respiratory, cardiovascular, urological and digestive diseases. 3.Individuals with orthopedic or other neurological diseases that limit gait. 4.Individuals with a pulse at rest of 120 / min or more, diastolic blood pressure of 120 mmHg or more, systolic blood pressure of 200 mmHg or more. 5.Individuals who are receiving the rTMS or TDCS within 3 month. 6.Individuals who have received the BT-X within 3 month.

Design outcomes

Primary

MeasureTime frame
Ten meter walk test

Secondary

MeasureTime frame
1)Fugl-Meyer Assessment on Lower Extremity 2)Function Independent Measure Walk item 3)Modified Ashworth scale 4)Functional Ambulation Categories 5)Berg Balance Scale 6)Timed Up and Go test (TUG) 7)kinematic gait analysis 8)Electromyography 9)questionnaires for therapist 10)questionnaires for patient

Contacts

Public ContactKoji Ohata

Human Health Sciences, Graduate school of Medicine, Kyoto University

ohata.koji.7n@kyoto-u.ac.jp+81-75-751-3918

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026